Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
Data
2019
Autores
Gomes, Luis Eduardo Miani
da Silva, Francesca Aparecida Ramos
Pascoal, Lívia Bitencourt
Ricci, Renato Lazarin
Nogueira, Guilherme
Camargo, Michel Gardere
de Lourdes Setsuko Ayrizono, Maria
Fagundes, João José
Leal, Raquel Franco